Research & Financial Highlights
• View our 2022 Research Highlights
• View our 2022 Financial Highlights
Crohn’s and Colitis Canada has invested over $145 million in more than 390 research projects since 1974.
In 2022, $5.3 million was invested in research activities.
Last year, we supported:
41
established IBD scientists
3
Early career researchers
37
Research projects and initiatives backed by Crohn’s and Colitis Canada funds
23
Major hospitals and universities were supported nationally
7
Research awards that were given to our funded scientists to recognize their innovative work
In these endeavors, there were some new findings:
- Our Grants-In-Aid (GIA) program supports the research of Dr. Ken Croitoru, who investigated the link between the microbiome and the origins of Crohn’s disease.
- The Innovation Grant (INN) enabled Dr. Eileen Crowley and Dr. Roberta Berard to study the prevalence of arthritis among pediatric and adult IBD patients, with the aim of improving their quality of life.
Crohn’s and Colitis Canada-affiliated researchers and healthcare providers attended the Meeting of the Minds Conference, a yearly event that brings together Canada’s skilled community of healthcare providers and researchers specializing in inflammatory bowel disease (IBD). The conference serves as a platform for sharing the latest research findings and best practices in clinical care for IBD.
Attendance included:
- 51 nurses attended the annual CANIBD (Canadian Nursing in IBD) Conference
- 98 MDs
- 44 faculty members
- 23 allied health professionals (Pharmacists, Dietitians, and Research Coordinators)
- 52 nurses
- 24 fellows
Read a recap of the 2022 Meeting of the Minds by Peter Dobranowski.
Total 202 Revenue: $13.6 million
Download our 2022 Audited Financials
Read how Crohn’s and Colitis Canada is spreading awareness >